The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Graham G. Walmsley since 2020.
This trader's CIK number is 1777517.
At the time of last reporting, Graham G. Walmsley was the Officer of Akero Therapeutics, Inc.. (stock ticker symbol AKRO).
Also see all insider trading activities at Akero Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | OLMA | 700,761 | $4,730,136 | 1,875,761 | $22,178,886 | 0 | $0 |
| 2023 | OLMA | 640,000 | $6,879,937 | 0 | $0 | 0 | $0 |
| 2020 | OLMA | 1,160,000 | $22,040,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AKRO | 400,000 | $18,387,920 | 0 | $0 | 0 | $0 |
| 2023 | AKRO | 800,000 | $22,531,199 | 0 | $0 | 0 | $0 |
| 2020 | AKRO | 0 | $0 | 0 | $0 | 2,168 | $43,294 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ALXO | 995,000 | $20,045,000 | 0 | $0 | 0 | $0 |
1. Olema Pharmaceuticals, Inc. (OLMA)
2. Akero Therapeutics, Inc. (AKRO)
3. Alx Oncology Holdings Inc (ALXO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-17 | OLMA | Sale | 700,761 | 6.75 | 4,730,136 |
| 2024-12-17 | OLMA | Buy | 700,761 | 6.75 | 4,730,136 |
| 2024-06-04 | OLMA | Sale | 1,175,000 | 14.85 | 17,448,750 |
| 2023-09-12 | OLMA | Buy | 508,130 | 9.84 | 4,999,999 |
| 2023-12-05 | OLMA | Buy | 131,870 | 14.26 | 1,879,938 |
| 2020-11-23 | OLMA | Buy | 1,160,000 | 19.00 | 22,040,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-25 | AKRO | Buy | 91,309 | 44.75 | 4,085,803 |
| 2025-03-26 | AKRO | Buy | 58,691 | 43.01 | 2,524,417 |
| 2025-03-27 | AKRO | Buy | 50,000 | 43.55 | 2,177,700 |
| 2025-01-30 | AKRO | Buy | 200,000 | 48.00 | 9,600,000 |
| 2023-12-08 | AKRO | Buy | 100,000 | 19.83 | 1,982,900 |
| 2023-12-01 | AKRO | Buy | 50,000 | 17.00 | 849,750 |
| 2023-11-30 | AKRO | Buy | 50,000 | 16.90 | 844,849 |
| 2023-08-08 | AKRO | Buy | 25,000 | 42.06 | 1,051,475 |
| 2023-07-28 | AKRO | Buy | 30,000 | 42.69 | 1,280,700 |
| 2023-08-01 | AKRO | Buy | 25,000 | 43.26 | 1,081,525 |
| 2023-09-19 | AKRO | Buy | 400,000 | 26.00 | 10,400,000 |
| 2023-05-19 | AKRO | Buy | 120,000 | 42.00 | 5,040,000 |
| 2020-03-30 | AKRO | Option Ex | 2,168 | 19.97 | 43,294 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-14 | ALXO | Buy | 20,000 | 76.00 | 1,520,000 |
| 2020-07-21 | ALXO | Buy | 975,000 | 19.00 | 18,525,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Graham G. Walmsley (Officer of Akero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.